A study to determine the efficacy and safety of fasinumab for the treatment of adults with lower back pain

Mise à jour : Il y a 4 ans
Référence : EUCTR2015-003782-28

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To evaluate the efficacy of fasinumab compared to placebo as measured by the change from baseline in the average daily low back pain intensity (LBPI) NRS score.


Critère d'inclusion

  • Chronic Low Back Pain